late trade new york stock exchang baxter
fell 12.5 cent $ 36.375
pump ventricular assist devic vad
replac heart take main chamber
function send blood bodi simpler less
invas artifici heart vad expect put
widespread perman use mechan heart
prototyp power extern wire tube
penetr chest alreadi use experiment keep
heart-failur patient aliv wait heart
transplant
novacor base oakland calif. thermo
cardiosystem inc. woburn mass. main competitor
race develop perman implant vad
power transmit magnet skin
dispens extern consol protrud wire
physician hope devic replac need heart
transplant mani case
novacor said continu develop n100 pump
use clinic trial extern power
consol bridg transplant n100 howev
yet put extens reliabl test
novacor discontinu devic n120 vad
far pass two-year reliabl test continu
run feder heart institut consid
prerequisit clinic test perman implant
vad said claud lenfant director institut clinic
test perman implant n120 expect
begin last fall ad delay various
problem
linda strauss novacor spokeswoman said
problem get electron compon n120
gave us chanc step back reassess overal goal
decid make sens move forward two
devic moreov n120 never intend
wide avail commerci product said
ad two-year reliabl test n100
wo necessarili requir launch clinic trial
perman implant version pump
novacor said temporari version n100 power
extern consol alreadi use 370 day
individu await transplant
